On Tuesday September 26th, Hemerion welcomed Guillaume Pépy, President of Initiative France, at the head of a delegation made up of representatives of the Initiative France network and its partners, specialists in the creation of innovative companies.
This was an opportunity to highlight the clinical progress made by our team in the treatment of glioblastoma and to demonstrate the operation of the latest version of our Heliance® illumination platform.
Founded in 2020, Hemerion received early funding from Hodéfi, a major player in the creation of innovative companies in the French Hauts-de-France region and a member of the national Initiative France network, which brings together over 200 associations in France dedicated to business creation and takeovers. Each year, Initiative France supports the creation of more than 20,000 businesses throughout France.
On the occasion of Hodefi’s 40th anniversary, Hemerion welcomed a delegation led by Guillaume Pepy, Chairman of Initiative France and former Chairman of the SNCF (French national railways).
Cette délégation était composée de représentants d’Initiative France, d’Hodéfi et de BNP Parbias, ainsi que de plusieurs journalistes ( Les Echos, La Voix du Nord, J’aime les Start-Ups, IT for Business, la Gazette du Nord).
L’échange avec la délégation a permis d’évoquer les progrès rapides enregistrés par Hemerion dans son développement clinique, avec l’obtention récente d’une autorisation de la FDA pour un essai clinique aux USA et son plan de financement. La délégation a pu participer à une démonstration grandeur nature de l’utilisation de la plateforme d’illumination Heliance® conçue par Hemerion pour améliorer le traitement du glioblastome.